Alzheimer research, two sides of the story

Alzheimer; News from the web:

Sometimes it is difficult for your editor to figure out what the real headlines are. Today is such a day with conflicting headlines rolling over my desk.

Here are two stories that sound very different but are both good to read. The bottom line is that although the one will say the glass is half full and the other the glass is half empty, we feel there is still enough in the glass to be happy about:

Drugs firm expands research teams worldwide to crack potentially lucrative market

Companies ‘giving up’ on Alzheimer’s drug

visit us at